PRM Big Pharma Split Corp.
14.04CAD-2.64%Mkt Cap: 13.42M $P/E: —4d ago
Industry Peers
Capital Markets$298.89BUSDP/E 15.4
$262.80BUSDP/E 13.9
$167.23BUSDP/E 17.6
$150.45BUSDP/E 35.0
$101.36BUSDP/E 49.9
$28.44BUSDP/E 11.4
$24.92BUSDP/E 25.4
$22.29BUSDP/E 24.4
$22.15BUSDP/E 16.6
$16.46BUSD
$15.85BUSD
$14.32BUSDP/E 10.2
$13.59BUSD
$11.48BUSD
$11.05BUSD
$10.91BUSDP/E 11.0
$10.61BUSDP/E 12.6
$10.06BUSDP/E 14.8
$9.35BUSDP/E 12.6
$8.83BUSDP/E 20.9
Key Statistics
Company
Market Cap13.42M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)3.66M USD
Revenue/Share—
Last Price14.04 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorFinancial Services
IndustryCapital Markets
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.95
EPS (TTM)—
EPS (Forward)—
52W Range
11.5854% of range16.10
52W High16.10 CAD
52W Low11.58 CAD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin90.55%
ROE27.53%
ROA15.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-648.25K USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh14.80 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate1.24 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateOct 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.31M
Float—
Insiders—
Institutions—
Technical
SMA 5014.91 (-5.8%)
SMA 20014.27 (-1.6%)
Beta—
S&P 52W Chg—
Avg Vol (30d)2.20K
Avg Vol (10d)1.32K
Technical Indicators
RSI (14)40.1
MACD-0.0539
MACD Signal0.0219
MACD Hist.-0.0758
BB Upper15.91 CAD
BB Middle14.90 CAD
BB Lower13.89 CAD
BB Width13.59%
ATR (14)0.3383 CAD
Vol Ratio (20d)2.21x